Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 39Squamous Cell Carcinoma of Head and Neck 20Lung Neoplasms 20Oropharyngeal Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Urinary Bladder Neoplasms 7Uterine Cervical Neoplasms 6Endometrial Neoplasms 6Carcinoma 6Pancreatic Neoplasms 5Mouth Neoplasms 5Colorectal Neoplasms 5Cholangiocarcinoma 5Biliary Tract Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Laryngeal Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Squamous Cell 4Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2

Interventions

Cyclophosphamide 4Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2liposomal doxorubicin 2ivosidenib 2cabozantinib 2X-Rays 2Topotecan 2Specimen Handling 2Radiation 2Phantoms, Imaging 2Nuclear Medicine Department, Hospital 2Irinotecan 2Eflornithine 2Congresses as Topic 2trifluridine tipiracil drug combination 1tazemetostat 1talazoparib 1palbociclib 1olaparib 1larotrectinib 1irinotecan sucrosofate 1ganitumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Cisplatin × 30 days × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡